Literature DB >> 10882679

CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes.

M C Cheeran1, G Gekker, S Hu, S L Yager, P K Peterson, J R Lokensgard.   

Abstract

Cytomegalovirus-stimulated CD4(+) lymphocytes from seropositive but not seronegative donors suppressed viral gene expression in primary human astrocytes. This suppressive activity was mediated through soluble factors. These findings suggest that CD4(+) lymphocytes play a role in defense of the brain against cytomegalovirus.

Entities:  

Mesh：

Year:  2000        PMID： 10882679      PMCID： PMC95941          DOI： 10.1128/CDLI.7.4.710-713.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  29 in total

1.  Media components influence viral gene expression assays in human fetal astrocyte cultures.

Authors:  M McCarthy; C Wood; L Fedoseyeva; S R Whittemore
Journal:  J Neurovirol       Date:  1995-09       Impact factor: 2.643

Review 2.  Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation.

Authors:  W F Hickey
Journal:  Brain Pathol       Date:  1991-01       Impact factor: 6.508

3.  T cell subsets and cytomegalovirus retinitis in human immunodeficiency virus-infected patients.

Authors:  M L Tay-Kearney; C Enger; R D Semba; W Royal; J P Dunn; D A Jabs
Journal:  J Infect Dis       Date:  1997-09       Impact factor: 5.226

4.  Cytokines released by human peripheral blood mononuclear cells inhibit the production of early and late cytomegalovirus proteins.

Authors:  S Torigoe; D E Campbell; S E Starr
Journal:  Microbiol Immunol       Date:  1997       Impact factor: 1.955

Review 5.  Inflammation in the nervous system.

Authors:  V H Perry; M D Bell; H C Brown; M K Matyszak
Journal:  Curr Opin Neurobiol       Date:  1995-10       Impact factor: 6.627

6.  Analysis of the proliferative T cell response to human cytomegalovirus major immediate-early protein (IE1): phenotype, frequency and variability.

Authors:  J L Davignon; D Clément; J Alriquet; S Michelson; C Davrinche
Journal:  Scand J Immunol       Date:  1995-03       Impact factor: 3.487

7.  Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.

Authors:  I Pavić; B Polić; I Crnković; P Lucin; S Jonjić; U H Koszinowski
Journal:  J Gen Virol       Date:  1993-10       Impact factor: 3.891

8.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

Review 9.  Cytokines in inflammatory brain lesions: helpful and harmful.

Authors:  J E Merrill; E N Benveniste
Journal:  Trends Neurosci       Date:  1996-08       Impact factor: 13.837

10.  Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism.

Authors:  C C Chao; S Hu; W S Sheng; D Bu; M I Bukrinsky; P K Peterson
Journal:  Glia       Date:  1996-03       Impact factor: 7.452
View more
  3 in total

1.  CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10.

Authors:  Maxim C-J Cheeran; Shuxian Hu; Wen S Sheng; Phillip K Peterson; James R Lokensgard
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  Titanium Dioxide Nanoparticles Evoke Proinflammatory Response during Murine Norovirus Infection Despite Having Minimal Effects on Virus Replication.

Authors:  Sudhakar Agnihothram; Lisa Mullis; Todd A Townsend; Fumiya Watanabe; Thikra Mustafa; Alexandru Biris; Mugimane G Manjanatha; Marli P Azevedo
Journal:  Int J Nanotechnol Eng Med       Date:  2016-12-05

Review 3.  New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.

Authors:  Jan Korbecki; Izabela Gutowska; Ireneusz Kojder; Dariusz Jeżewski; Marta Goschorska; Agnieszka Łukomska; Anna Lubkowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Oncotarget       Date:  2018-01-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.